160 related articles for article (PubMed ID: 34295698)
1. LncRNA XIST serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell via miR-497-5p/FOXO1 axis.
Li Y; Yuan X; Shi Z; Wang H; Ren D; Zhang Y; Fan Y; Liu Y; Cui Z
Cardiovasc Diagn Ther; 2021 Jun; 11(3):716-725. PubMed ID: 34295698
[TBL] [Abstract][Full Text] [Related]
2. METTL14-mediated lncRNA XIST silencing alleviates GDM progression by facilitating trophoblast cell proliferation and migration via the miR-497-5p/FOXO1 axis.
Li Y; Liu Y; Yao X; Wang H; Shi Z; He M
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23621. PubMed ID: 38229320
[TBL] [Abstract][Full Text] [Related]
3. miR-134-5p promotes inflammation and apoptosis of trophoblast cells via regulating FOXP2 transcription in gestational diabetes mellitus.
Ke W; Chen Y; Zheng L; Zhang Y; Wu Y; Li L
Bioengineered; 2022 Jan; 13(1):319-330. PubMed ID: 34969354
[TBL] [Abstract][Full Text] [Related]
4. miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability.
Zhou X; Xiang C; Zheng X
Diagn Pathol; 2019 Oct; 14(1):119. PubMed ID: 31653266
[TBL] [Abstract][Full Text] [Related]
5. LncRNA XIST promotes insulin resistance in gestational diabetes mellitus via the microRNA-181b-5p/NDRG2 axis.
Xu Y; Kang X; Liu H; Jiang H; Wang W
Gen Physiol Biophys; 2023 Sep; 42(5):443-455. PubMed ID: 37702449
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-1323 serves as a biomarker in gestational diabetes mellitus and aggravates high glucose-induced inhibition of trophoblast cell viability by suppressing TP53INP1.
Liu L; Zhang J; Liu Y
Exp Ther Med; 2021 Mar; 21(3):230. PubMed ID: 33603839
[TBL] [Abstract][Full Text] [Related]
7. circMAP3K4 regulates insulin resistance in trophoblast cells during gestational diabetes mellitus by modulating the miR-6795-5p/PTPN1 axis.
Du R; Wu N; Bai Y; Tang L; Li L
J Transl Med; 2022 Apr; 20(1):180. PubMed ID: 35449053
[TBL] [Abstract][Full Text] [Related]
8. LncRNA OIP5-AS1 Signatures as a Biomarker of Gestational Diabetes Mellitus and a Regulator on Trophoblast Cells.
Li Y; Liu L
Gynecol Obstet Invest; 2021; 86(6):509-517. PubMed ID: 34844256
[TBL] [Abstract][Full Text] [Related]
9. miR-942-5p Regulates Proliferation, Invasion and EMT of Trophoblast Cells in Gestational Diabetes by Targeting the CEBPA.
Chu Q; Zhong X; Lu Y; Xu Y
Altern Ther Health Med; 2024 Jan; ():. PubMed ID: 38290456
[TBL] [Abstract][Full Text] [Related]
10. LncRNA XIST Engages in Psoriasis via Sponging miR-338-5p to Regulate Keratinocyte Proliferation and Inflammation.
Wang Y; Jiang F; Chen F; Zhang D; Wang J
Skin Pharmacol Physiol; 2022; 35(4):196-205. PubMed ID: 35231918
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-362-5p promotes the proliferation and inhibits apoptosis of trophoblast cells via targeting glutathione-disulfide reductase.
Zhang C; Zhao D
Bioengineered; 2021 Dec; 12(1):2410-2419. PubMed ID: 34107852
[TBL] [Abstract][Full Text] [Related]
12. miR-520h Inhibits cell survival by targeting mTOR in gestational diabetes mellitus.
Wen J; Bai X
Acta Biochim Pol; 2021 Feb; 68(1):65-70. PubMed ID: 33620957
[TBL] [Abstract][Full Text] [Related]
13. miR-96-5p: A potential diagnostic marker for gestational diabetes mellitus.
Yu X; Liu Z; Fang J; Qi H
Medicine (Baltimore); 2021 May; 100(21):e25808. PubMed ID: 34032694
[TBL] [Abstract][Full Text] [Related]
14. MiR-155-5p improves the insulin sensitivity of trophoblasts by targeting CEBPB in gestational diabetes mellitus.
Zhang H; Jiang Y; Zhu S; Wei L; Zhou X; Gao P; Zhang J; Chen Y; Du Y; Fang C; Su R; Li J; Wang S; Feng L
Placenta; 2024 Mar; 148():1-11. PubMed ID: 38325118
[TBL] [Abstract][Full Text] [Related]
15. LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.
Liu C; Lu Z; Liu H; Zhuang S; Guo P
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32149330
[TBL] [Abstract][Full Text] [Related]
16. Mechanism associated with aberrant lncRNA MEG3 expression in gestational diabetes mellitus.
Zhang H
Exp Ther Med; 2019 Nov; 18(5):3699-3706. PubMed ID: 31656536
[TBL] [Abstract][Full Text] [Related]
17. miR-17-5p Promotes Glucose Uptake of HTR8/SVneo Trophoblast Cells by Inhibiting TXNIP/NLRP3 Inflammasome Pathway.
Jiang Y; Wei L; Zhang H; Chen Y; Gao P; Zhang J; Zhou X; Zhu S; Du Y; Fang C; Li J; Feng L; He M; Wang S; Yu J
Diabetes Metab Syndr Obes; 2022; 15():3361-3374. PubMed ID: 36341225
[TBL] [Abstract][Full Text] [Related]
18. Serum miR-195-5p is upregulated in gestational diabetes mellitus.
Wang J; Pan Y; Dai F; Wang F; Qiu H; Huang X
J Clin Lab Anal; 2020 Aug; 34(8):e23325. PubMed ID: 32301163
[TBL] [Abstract][Full Text] [Related]
19. MiR-137 Restricts the Viability and Migration of HTR-8/SVneo Cells by Downregulating FNDC5 in Gestational Diabetes Mellitus.
Peng HY; Li MQ; Li HP
Curr Mol Med; 2019; 19(7):494-505. PubMed ID: 31109274
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA X inactive specific transcript (XIST) radiosensitizes non-small cell lung cancer (NSCLC) cells through regulation of miR-16-5p/WEE1 G2 checkpoint kinase (WEE1) axis.
Du R; Jiang F; Yin Y; Xu J; Li X; Hu L; Wang X
Int J Immunopathol Pharmacol; 2021; 35():2058738420966087. PubMed ID: 33583218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
